Journal: Current Cancer Drug Targets Volume: 6 Issue: 8 Year: 2006 Page: 671-679 Author(s): A. Ferrajoli, S. Faderl, F. Ravandi, Z. Estrov
Journal: Current Pharmacogenomics and Personalized Medicine Volume: 10 Issue: 1 Year: 2012 Page: 54-69 Author(s): Rekha Jain,Asmita Dasgupta,Aliasgar Moiyadi,Sanjeeva Srivastava
Journal: Current Neuropharmacology Volume: 21 Issue: 10 Year: 2023 Page: 2049-2069 Author(s):
Journal: Current Signal Transduction Therapy Volume: 4 Issue: 3 Year: 2009 Page: 201-221 Author(s): Charles Jay Malemud, Eric Pearlman
Journal: Current Signal Transduction Therapy Volume: 1 Issue: 3 Year: 2006 Page: 337-351 Author(s): Edith Pfitzner, Frank Nonnenmacher, Daniela Baus
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 19 Issue: 5 Year: 2019 Page: 656-664 Author(s): Yunjuan Zhao,Yunliang Xie,Wangen Li
Journal: Current Pharmaceutical Design Volume: 10 Issue: 2 Year: 2004 Page: 2839-2850 Author(s): E. Pfitzner, S. Kliem, D. Baus, M. C. Litterst
Journal: Current Signal Transduction Therapy Volume: 7 Issue: 3 Year: 2012 Page: 187-201 Author(s): Daria Domanska, Ewa Brzezianska
Journal: Current Enzyme Inhibition Volume: 2 Issue: 2 Year: 2006 Page: 163-171 Author(s): Shahab Uddin, Azhar R. Hussain, Khawla S. Al-Kuraya
Journal: Mini-Reviews in Medicinal Chemistry Volume: 17 Issue: 3 Year: 2017 Page: 268-294 Author(s): Eleni Vrontaki,Georgia Melagraki,Antreas Afantitis,Thomas Mavromoustakos,George Kollias
Previous Next